Andre Watson –

Andre is Founder of Ligandal, a gene editing delivery company. Ligandal has developed a breakthrough technique for delivering gene editing tools such as CRISPR and TALEN with non-viral nanocarriers, circumventing many of the issues associated with use of viruses in gene therapy. Andre is intent on developing the delivery technologies necessary for making CRISPR succeed. Andre has been an invited speaker at a number of events including BIO’s startup stadium, Partnership Opportunities in Drug Delivery (PODD), IEEE Nanotechnology Counsel’s “Nanotechnology in Biosystems, Medicine and Health” symposium, the Foresight Institute’s Atomic Precision Nanomedicine workshop, and the Genetics of Aging and Longevity Conference.